Regulation of NADPH Oxidase by Phospholipase D and the EC Cytoskeleton
磷脂酶 D 和 EC 细胞骨架对 NADPH 氧化酶的调节
基本信息
- 批准号:8214990
- 负责人:
- 金额:$ 30.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsActomyosinAcute Lung InjuryAdaptor Signaling ProteinAddressAdherens JunctionAdhesivesAgonistAlveolarAnimal ModelAreaBindingBiological AssayBiologyBlood VesselsBlood capillariesBlood gasCell AdhesionCell Culture TechniquesCell membraneCellsChemicalsCo-ImmunoprecipitationsCollaborationsComplexCytoskeletal ModelingCytoskeletonDataDown-RegulationElementsEndothelial CellsEndotheliumEnsureEnvironmentEnvironmental air flowEpithelialEquilibriumExhibitsFloodsFocal AdhesionsFunctional disorderGIT2 geneGelGenetic PolymorphismGuanosine Triphosphate PhosphohydrolasesHepatocyte Growth FactorHumanHuman ResourcesHypoxemiaImageImaging TechniquesIn VitroInfiltrationInflammationInflammatoryInjuryKnock-outKnockout MiceLeukocytesLiquid substanceLungMaintenanceMechanical StressMechanical ventilationMechanicsMediatingMicrofilamentsModelingMolecularMonomeric GTP-Binding ProteinsMorbidity - disease rateMusMyosin Light Chain KinaseNADPNADPH OxidaseNamesPathogenesisPathologicPathway interactionsPatientsPatternPeptidesPeripheralPermeabilityPhospholipase DPhosphorylationPhosphorylcholinePhysiologicalPrincipal InvestigatorProcessProductionPropertyProtein IsoformsProteinsPublishingPulmonary CirculationPulmonary artery structureReactive Oxygen SpeciesReagentRegimenRegulationResearch PersonnelResolutionResourcesRoleScaffolding ProteinScientistSignal TransductionStimulusStretchingSyndromeTechniquesTertiary Protein StructureTestingThrombinTidal VolumeTight JunctionsTimeTransfectionVariantVascular Endothelial Growth FactorsVascular PermeabilitiesVentilator-induced lung injuryattenuationcapillarycytokinehuman EMS1 proteinin vivoinsightmortalitymutantnew technologynoveloverexpressionpaxillinprogramsprotective effectresponserhoshear stresssphingosine 1-phosphatesynergism
项目摘要
Compromise of the pulmonary endothelial cell (EC) barrier is induced by mechanical stress which is
associated with ventilator-induced lung injury (VILI), This process leads to increased vascular permeability,
alveolar flooding, leukocyte infiltration, hypoxemia, and increased morbidity and mortality. Project #3
scientists have previously identified cytoskeletal mechanisms of EC barrier regulation by barrier-protective
strategies (oxidized phosphocholine, sphingosine 1-phosphate, physiologic shear stress and cyclic stretch
(CS) and barrier-disruptive mechanical and chemical stimuli (thrombin, pathologic CS). In addition, these
PPG investigator have described the critical involvement of small GTPases Rac and Rho in remodeling of
EC cytoskeleton and cell contacts essential for EC barrier regulation. Our published results and preliminary
data strongly suggest that magnitude-dependent modulation of Rac and Rho activities by CS significantly
impacts agonist-induced EC permeability changes. The Project #3 hypothesis is that pathologic CS and
vascular endothelial growth factor (VEGF), known to be elevated during VILI, promote lung endothelial
barrier dysfunction via synergistic effects on Rho pathway-mediated EC permeability. These processes are
counterbalanced by Rac-dependent mechanisms induced by barrier-protective stimuli such as hepatocyte
growth factor (HGF) and physiologic stretch. We speculate that focal adhesions may act as mechanosensors
and modulate small GTPase activities via specific paxillin interactions with Rac and Rho protein regulators.
Specific Aim #1 will study synergistic effects between pathologic CS and VEGF on activation of Rhomediated
EC barrier dysfunction. Specific Aim #2 will define barrier-protective strategies in amelioration of
VILI-associated EC barrier dysfunction via changes in a balance between the Rho and Rac activities.
Specific Aim #3 will study novel mechanisms of Rac/Rho regulation by mechanochemical factors via
interactions between wild type paxillin (or/and paxillin containing the Gly73Ser polymorphism) interactions
with modulators of Rac and Rho activity (GIT2, betaPIX, PAK1 and p190RhoGAP). These studies will
uncover novel molecular mechanisms involved in the pathogenesis and resolution of ventilator-induced lung
injury.
肺内皮细胞(EC)屏障的妥协是由机械应力引起的,
与呼吸机诱导的肺损伤(VILI)相关,此过程导致血管通透性增加,
肺泡洪水,白细胞浸润,低氧血症以及发病率和死亡率增加。项目#3
科学家以前已经确定了通过屏障保护的EC屏障调节的细胞骨架机制
策略(氧化的磷胆碱,1-磷酸盐,生理剪切应力和环状拉伸
(CS)和屏障干扰性的机械和化学刺激(凝血酶,病理CS)。另外,这些
PPG研究者描述了小型GTPases RAC和RHO在重塑中的关键参与
EC细胞骨架和细胞接触对于EC屏障调节必不可少的。我们发表的结果和初步
数据强烈表明,CS对RAC和RHO活动的幅度依赖性调制
影响激动剂引起的EC渗透性变化。项目#3假设是病理CS和
血管内皮生长因子(VEGF)已知在VILI期间升高,促进肺部内皮
通过对RHO途径介导的EC渗透性的协同作用的屏障功能障碍。这些过程是
由屏障保护刺激(例如肝细胞)引起的RAC依赖机制的平衡
生长因子(HGF)和生理拉伸。我们推测焦点粘连可能充当机械传感器
并通过特异性的帕克西林与RAC和RHO蛋白调节剂进行调节小型GTPase活性。
特定的目标#1将研究病理CS和VEGF之间的协同作用对综艺的激活
EC屏障功能障碍。特定目标#2将定义屏障保护策略
VILI相关的EC屏障功能障碍通过RHO和RAC活动之间的平衡发生变化。
特定目的#3将通过机械化学因素研究RAC/RHO调节的新型机制
野生型帕克西林(OR/和含有Gly73ser多态性的Paxillin)相互作用之间的相互作用之间的相互作用
与RAC和RHO活动的调节剂(Git2,Betapix,Pak1和P190Rhogap)。这些研究会
揭示了与呼吸机诱导的肺的发病机理和分辨率有关的新型分子机制
受伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VISWANATHAN NATARAJAN其他文献
VISWANATHAN NATARAJAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VISWANATHAN NATARAJAN', 18)}}的其他基金
Role of Sphingolipids in the Pathobiology of Lung Injury
鞘脂在肺损伤病理学中的作用
- 批准号:
8264982 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
Role of Sphingolipids in the Pathobiology of Lung Injury
鞘脂在肺损伤病理学中的作用
- 批准号:
8502315 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
Role of Sphingolipids in the Pathobiology of Lung Injury
鞘脂在肺损伤病理学中的作用
- 批准号:
8857527 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
Role of Sphingolipids in the Pathobiology of Lung Injury
鞘脂在肺损伤病理学中的作用
- 批准号:
8676881 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
Role of Sphingolipids in the Pathobiology of Lung Injury
鞘脂在肺损伤病理学中的作用
- 批准号:
8079342 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
Regulation of NADPH Oxidase by Phospholipase D and the EC Cytoskeleton
磷脂酶 D 和 EC 细胞骨架对 NADPH 氧化酶的调节
- 批准号:
7407786 - 财政年份:2008
- 资助金额:
$ 30.06万 - 项目类别:
Regulation of endothelial NADPH oxidase by the cytoskeleton
细胞骨架对内皮 NADPH 氧化酶的调节
- 批准号:
7347544 - 财政年份:2007
- 资助金额:
$ 30.06万 - 项目类别:
Nox 4 in Endothelial Cell ROS Production, Signaling and Motility
Nox 4 在内皮细胞 ROS 产生、信号传导和运动中的作用
- 批准号:
7136887 - 财政年份:2006
- 资助金额:
$ 30.06万 - 项目类别:
相似国自然基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
- 批准号:82360313
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
丙酮酸激酶催化肌动球蛋白磷酸化调控肉嫩度的分子机制
- 批准号:32372263
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
鱼糜肌动球蛋白的增效转化及其氧化控制分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:59 万元
- 项目类别:面上项目
基于Pickering纳米乳液脂质诱导肌动球蛋白凝胶的空间位阻效应及其机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
基于Pickering纳米乳液脂质诱导肌动球蛋白凝胶的空间位阻效应及其机制
- 批准号:32172242
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
相似海外基金
Calpain/talin/MLCP axis in pulmonary endothelial barrier regulation
钙蛋白酶/talin/MLCP轴在肺内皮屏障调节中的作用
- 批准号:
10522290 - 财政年份:2022
- 资助金额:
$ 30.06万 - 项目类别:
Functional Characterization of ALI-Associated MYLK SNPs
ALI 相关 MYLK SNP 的功能表征
- 批准号:
8646352 - 财政年份:2014
- 资助金额:
$ 30.06万 - 项目类别:
Functional Characterization of ALI-Associated MYLK SNPs
ALI 相关 MYLK SNP 的功能表征
- 批准号:
8968757 - 财政年份:2014
- 资助金额:
$ 30.06万 - 项目类别: